Effect of Multiple Dose Levels of SRT2379 on Endotoxin-Induced Inflammation
Clinical trial NCT01416376 · COMPLETED
Trial details
- NCT number
- NCT01416376
- Sponsor
- Sirtris, a GSK Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-30
- Primary completion
- 2011-12-12
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.